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1 negative rhabdomyosarcoma (RD) cells, HRV8 accumulated in the cells but caused CPE only after 3 days
when used at high MOI. Adaptation by three blind passages alternating between RD and HeLa cells resulted in
variant HRV8v with decreased stability at acidic pH allowing for productive infection in the absence of ICAM-
1. HRV8v produced CPE at 10 times lower MOI within 1 day. Confocal ﬂuorescence microscopy colocalization
and the use of pharmacological and dominant negative inhibitors revealed that viral uptake is clathrin,
caveolin, and ﬂotillin independent. However, it is blocked by dynasore, amiloride, and EIPA. Furthermore,
HRV8v induced FITC-dextran uptake and colocalized with this ﬂuid phase marker. Except for the complete
inhibition by dynasore, the entry pathway of HRV8v via HS is similar to that of HRV14 in RD cells that
overexpress ICAM-1.laas).
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Human rhinoviruses are a major cause of the common cold
(Heikkinen and Jarvinen, 2003). They include three species (HRV-A,
B, and C) of the genus Enterovirus, family Picornaviridae (Palmenberg
et al., 2009). Twelve HRV-A (the minor receptor group) (Vlasak et al.,
2005b), bind low-density lipoprotein receptor (LDLR), LDLR related
protein (LRP) (Hofer et al., 1994), and very-LDLR (VLDLR) (Marlovits
et al., 1998), while the remaining 61 HRV-A and all 26 HRV-B utilize
intercellular adhesionmolecule 1 (ICAM-1) for cell entry and infection
(Uncapher et al., 1991). The receptor(s) of the recently discovered
HRV-C clade is not known (McErlean et al., 2008). The minor group
virus HRV2 is internalized via the well-characterized clathrin-
dependent endocytic pathway (Snyers et al., 2003); however, similar
to other ligands, it can switch to different entry portals when this
pathway is blocked (Bayer et al., 2001). Having once arrived in
endosomal carrier vesicles or late endosomes, uncoating is triggeredby the acidic pH (Konecsni et al., 2009; Neubauer et al., 1987; Prchla
et al., 1994). Conversely, in major group HRVs the process is initiated
by the receptor, ICAM-1, itself (Bayer et al., 1999; Greve et al., 1991)
but assisted by the low endosomal pH (Nurani et al., 2003).
Attempts at adapting the major group HRV89 to bind LDL-
receptors resulted in variants replicating in cells lacking ICAM-1
expression (Reischl et al., 2001; Vlasak et al., 2005a). HRV54 was even
able to multiply in ICAM-1 negative rhabdomyosarcoma (RD) cells
without prior adaptation. However, HRV54 wt as well as the above
HRV89 variants had not acquired afﬁnity for LDL-receptors but rather
bound heparan sulphate (HS) and preserved their ability to attach to
ICAM-1 (Khan et al., 2007).
HS is present ubiquitously on the surface of most animal cells and
in the extracellular matrix where it has been implicated in numerous
biological functions including cell–matrix and cell–cell adhesion, cell
proliferation, motility and differentiation, blood coagulation, inﬂam-
mation, tumor progression and invasion, tissue regeneration, lipo-
protein metabolism and pathogen infections (reviewed in Bishop
et al., 2007). Although many ligands and viruses attach to HS
proteoglycans, data on cellular uptake are controversial. For example,
entry of cationic peptides binding to HS was ascribed either to the
clathrin-, the caveolin-, or the macropinocytic machinery (Duchardt
et al., 2007; Jones, 2007; Poon and Gariepy, 2007). Eosinophil cationic
Fig. 1. HRV8 wt uncoating but not entry correlates with poor infection of ICAM-1
negative RD cells. A) RD cells were grown on glass cover slips and infected with HRV8
wt at 300 TCID50/cell at 34 °C. After 30 min of continuous internalization, cells were
washed and ﬁxed with 4% paraformaldehyde. HRV8 was revealed with mouse
antiserum followed by Alexa Fluor 488 secondary antibody. Nuclei were stained with
DAPI. Cells were viewed under a LSM510 confocal microscope; one focal plane through
the cell body is shown. B) Virus at 107 TCID50 was incubated at 34 °C for 30 min in
isotonic 100 mM MES buffer of the indicated pH values and, after re-neutralization,
infectivity was determined by endpoint dilution. Mean and SD of 4 independent
experiments.
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cells exhibited characteristics of raft-dependent macropinocytosis
(Fan et al., 2007). Finally, HS-binding cationic polyplexes and
antibodies against HS were shown to enter in the absence of
functional clathrin and caveolin but co-localized with ﬂotillin and
trafﬁcked to late endosomes (Payne et al., 2007). An increasing
number of viruses have also been shown to use HS as (an alternative)
receptor but again, their entry pathway into the host cell is largely
ignored (Spillmann, 2001). These ambiguous results indicate that
uptake via HS is poorly understood. The involvement of proteoglycans
in viral infection and drug delivery underscores the importance to
investigate the mechanism underlying their uptake. We here report
on entry and trafﬁcking of HRV8v, a variant that binds HS and was
selected for replication in ICAM-1 negative rhabdomyosarcoma (RD)
cells. Employing pharmacological compounds, speciﬁc dominant-
negative inhibitors, and immunoﬂuorescence colocalization micros-
copy, we demonstrate that HRV8v enters RD cells via a dynamin-
dependent pathway that is independent of clathrin, caveolin, and
ﬂotillin.
Results
Wild type HRV8 enters rhabdomyosarcoma cells but replicates
inefﬁciently
HRV8 wt gave rise to CPE in ICAM-1 negative RD cells only upon
challenge at N100 TCID50/cell after three days. However, upon
continuous internalization for 30 min it readily entered RD cells and
accumulated in vesicular structures seen by confocal immunoﬂuo-
rescence microscopy of a single confocal slice through the cell body
(Fig. 1A and movie of deconvolved image stacks in Supplementary
material). Previously, we obtained variants of HRV89 (HRV89M) upon
34 serial blind passages alternating betweenHeLa and Hep-2 cells that
were able to replicate in these latter (ICAM-1 negative) cells (Reischl
et al., 2001; Vlasak et al., 2005a). For HRV8, only three such passages
in HeLa and RD cells were required for the appearance of a variant
(HRV8v) that replicated and produced CPE equally in RD cells stably
transfected to express human ICAM-1 (Newcombe et al., 2003) and in
RD wild type cells. HRV8v was less stable at low pH than wt HRV8; at
pH 5.6, a reduction of infectivity by almost 3 logs was observed
(Fig. 1B). This pH value is attained in endosomal carrier vesicles and
late endosomes in HeLa cells where it triggers uncoating of the minor
group virus HRV2 (Brabec et al., 2003; Gruenberger et al., 1991). In the
absence of the ‘catalytic’ activity of ICAM-1, HRV8v must be uncoated
by the low pH. Thus, decreased viral stability in acidic environment
correlates with productive infection in the ICAM-1 negative RD cells.
Employing the same strategy previously used to identify heparan
sulphate (HS) proteoglycan as an alternative receptor for HRV54
(Khan et al., 2007) and the HRV89 variants mentioned above, it
became clear that HRV8 also attaches to HS. This is exempliﬁed by the
inhibition of binding to RD cells with heparin (Fig. 2A), signiﬁcantly
reduced binding to CHO mutant cell lines pgsA-745 and pgsD-677
(Fig. 2B), and the complete inhibition of infection of RD cells by HRV8v
in the presence of heparin (Fig. 2C). PgsA-745 is deﬁcient in
xylosyltransferase synthesis and unable to produce glycosaminogly-
cans whereas pgsD-677 is doubly deﬁcient in N-acetylglucosaminyl-
transferase and glucuronyltransferase and fails to synthesize HS but
produces threefold-higher levels of chondroitin sulphate than wt. As
for the minor group virus HRV2 (Bayer et al., 1998) and the HS-
adapted variants above, HRV8v infection via HS was completely
blocked by baﬁlomycin A1, an inhibitor of endosomal H+-ATPases. On
the other hand, in RD-ICAM cells development of CPE was only
slightly affected by the drug (not shown). Collectively, these data
demonstrate that themore stable wt virus, although entering RD cells,
only inefﬁciently uncoats without the aid of ICAM-1. Therefore, apart
from receptor selection and entry, uncoating is a major determinantfor efﬁcient infection. Note that all subsequent experiments were
carried out with HRV8v to allow for functional assays (i.e. readout of
entry/uncoating via cleavage of eIF4G and viral replication).
HRV8v shows different staining patterns when entering via ICAM-1 or
via HS
HRV2 enters via clathrin-mediated endocytosis (CME) and HRV14
via a non-clathrin, non-caveolin, non-ﬂotillin dependent route (Khan
et al., 2010; Snyers et al., 2003). To study whether HRV8v follows any
of these pathways, RD cells were co-infected with HRV8v and HRV2
for 30 min followed by ﬁxation, speciﬁc staining, and immunoﬂuo-
rescence confocal microscopy. As seen in Fig. 3 (upper panels), there is
only a marginal overlap (arrowheads) indicating that the two virus
types localize to distinct compartments. HRV2 is delivered into early
(EEA1-positive) endosomes and then transferred into late endo-
somes. Some of the HRV8v appears to attain also this early
compartment. When the same experiment was conducted with
HRV89M, another HS-binding variant (see above and Vlasak et al.,
2005a), essentially complete overlap was observed (Fig. 3, middle
panel). Co-localization was also evident upon internalization of
HRV8v together with HRV14 in RD-ICAM cells, although the pattern
Fig. 2. In RD cells HRV8 binding and HRV8v infection depend on heparan sulphate. A)
RD cells grown in 24-well plates until almost conﬂuent were incubated with about
12,000 cpm of [35S]-labeled HRV8 for 1 h at room temperature in the absence or the
presence of 2 mg/ml heparin. Cells were washed with PBS and trypsinized and cell
associated radioactivity was determined by liquid scintillation counting. B) RD cells,
CHO-K1 (wild type control), and the mutants pgsA-745 and pgsD-677 grown in 6 well
plates were incubated with [35S]-labeled HRV8 as above, trypsinized, and scintillation
counted as above. Cell-associated radioactivity is given as percentage of total
radioactivity. Mean +/- SD of three experiments. C) RD cells grown in 96-well plates
were challenged with HRV8v at 10 TCID50/cell in the absence and in the presence of
2 mg/ml heparin and stained with crystal violet at 24 h pi.
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panels with upper panels). Presumably, this relates to the high
expression level of ICAM-1, which results in binding of large amounts
of virus and predominant uptake via this receptor. Taken together, the
above observations demonstrate that entry and intracellular trafﬁck-
ing of HRV2 and HRV8v are distinct. Unfortunately, because of its dual
receptor speciﬁcity, with this type of experiment it is not possible to
ﬁnd out whether HRV8v (when exclusively entering via HS) and
HRV14 (entering via ICAM-1) exploit different pathways.
Virus entry via HS is clathrin-independent
Because of the different intracellular localization of HRV2 and
HRV8v during continuous internalization, clathrin-dependent entry
for the latter virus is unlikely. For conﬁrmation, HRV8v was co-
internalized with human transferrin, a marker for CME. Cells were
washed and ﬁxed after 5 and 15 min of continuous co-internalization.
Note that attachment of HRV8v was found to be slow, particularly at
low temperature. This precluded examination of virus localization attimes shorter than 5 min. It is well known and also demonstrated by
our laboratories that under these conditions, most of the Alexa Fluor
568-labeled transferrin localizes in early endosomes and in the
perinuclear region at 5 min (Baravalle et al., 2005); confocal
immunoﬂuorescence microscopy demonstrated a clear separation
from HRV8v that largely remained at the cell periphery (Fig. 4A). At
15 min, transferrin had accumulated in the perinuclear region
whereas HRV8v was evenly distributed throughout the cell body.
Notably, co-localization, as determined with BioImageXD was about
1% at both time points. HRV2, used as a control, completely
overlapped with transferrin (90% overlap; not shown), although
their intracellular pathways separate rapidly (Brabec et al., 2006).
These data demonstrate that transferrin and HRV8v enter with
different kinetics and localize to different compartments, making
CME for HRV8v entry via HS improbable.
Direct proof for clathrin-independent entry via HSwas obtained by
using a GFP-tagged clathrin light chain. RD cells overexpressing GFP-
clathrin were challenged with virus and ﬁxed at 5 and 15 min pi. In
accordance with the previous results, there was no colocalization
between GFP-clathrin and HRV8v at either time (Fig. 4B) whereas
transferrin used as a control overlapped with GFP-clathrin at the early
time point (not shown).
Dominant negative inhibitors of clathrin-mediated endocytosis do not
affect virus entry
For further conﬁrmation of clathrin-independence, we used
dominant-negative (DN) mutants that potently interfere with the
normal functions of key proteins of the clathrin-dependent pathway.
The SH3 domain of amphiphysin (amphi-SH3) has been shown to
inhibit receptor mediated endocytosis of HRV2, transferrin, and
epidermal growth factor (Snyers et al., 2003; Wigge et al., 1997) by
impeding recruitment of dynamin to coated pits. Accordingly, RD cells
were transfected with myc-tagged amphi-SH3 followed by infection
with HRV8v. Confocal microscopy revealed no difference in entry in
the presence or absence of amphi-SH3 expression (Fig. 5, upper
panels). To assess clathrin function more directly, we also used the C-
terminal domain of AP180 (AP180-C), which has been shown
unequivocally to inhibit CME (Ford et al., 2001). Overexpression of
DN AP180-C also failed to modify entry of HRV8v in RD cells (Fig. 5,
lower panels); in contrast, both DN inhibitors readily prevented
transferrin internalization (Fig. 5, right panels). No staining of viral
protein was seen in the absence of permeabilization (not shown).
HRV8v colocalizes neither with cholera toxin B nor with caveolin-1
The caveolin pathway is the second best characterized cell entry
route. Although for various HS-binding ligands amacropinocytic entry
mode has been suggested, entry of FMDV via HS was reported to be
impaired upon knocking down caveolin-1 in MCF-10A cells (O'Don-
nell et al., 2008). Thus, it was of interest to investigate carefully the
involvement of caveolin in HRV8v virus entry. A possible role of
caveolin was evaluated by assessing co-localization of virus with
cholera toxin subunit B (CtxB). CtxB is a widely accepted marker of
this pathway although it has also been shown in association with
ﬂotillin- (Glebov et al., 2006) and clathrin-dependent endocytosis in
various cell types (Hansen et al., 2005; Torgersen et al., 2001). RD cells
were challenged with HRV8v in the presence of Alexa Fluor 488 CtxB
for 5 and 15 min at 34 °C, washed, and ﬁxed. Confocal microscopy
showed both ligands close to the cell surface but in distinct locations
at 5 min. At 15 min, CtxB had moved to the Golgi and concentrated in
the perinuclear region while HRV8v remained spread throughout the
cytosol (Fig. 6A). Again, there was virtually no colocalization (1% at
5 min and 5% at 15 min as determined with BioImageXD). These
results indicate that HRV8v and CtxB use different pathways to
different destinations within the cell. CtxB accumulated in typical
Fig. 3. HRV8v entering via HS or via ICAM-1 exhibits distinct intracellular localization patterns. RD cells (upper two rows) were challenged with pairs of the virus types indicated at
300 TCID50/cell for 30 min at 34 °C. Cells were washed and ﬁxed, and the respective virus was stained with corresponding type-speciﬁc antibody, followed by TxR- and Alexa Fluor
488-labeled secondary antibodies and viewed under a confocal microscope. Lower row, RD-ICAM cells were used. HRV89M is a HS-binding variant (Vlasak et al., 2005a). Nuclei were
stained with DAPI. Arrowheads point to sites of colocalization. Ten confocal stacks were combined. Bar, 10 μm.
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colocalize with CtxB (data not shown). These results deﬁnitely
exclude HRV8v transport to the Golgi. Further conﬁrmation by more
direct means was obtained via transfecting cells with caveolin-1
tagged with GFP, either at the N- (GFP-caveolin) or the C-terminus
(caveolin-GFP). The former construct also acts as a DN inhibitor of
caveolin function (Pelkmans et al., 2001). HRV8v colocalized neither
with GFP-caveolin nor with caveolin-GFP (Fig. 6B), furthermore,
expression of GFP-caveolin did not inhibit viral entry. We also stained
caveolin-1 by using anti-caveolin antibodies and assessed eventual
colocalization. Consistent with the previous results, no colocalization
of virus and caveolin-1 was observed (data not shown). We also
noticed that RD cells express very low levels of caveolin-1 while HeLa
and CHO cells contain high amounts of this protein. Nevertheless,
virus entry and eIF4G cleavage (see below) occurred equally in RD and
CHO-K1 cells (not shown). These results clearly exclude the
involvement of caveolin-1 in entry and intracellular trafﬁcking of
HRV8v via HS in RD cells.Entry via HS is ﬂotillin-1 independent
Flotilin-1 and -2 have been described as markers of a clathrin and
caveolin-independent pathway (Glebov et al., 2006) and more recent
data suggested involvement of ﬂotillin-1 in uptake of HS-binding
ligands (Payne et al., 2007). Therefore, having excluded entry of
HRV8v via clathrin- and caveolin-dependent routes it was of interest
to investigate whether ﬂotilin-1 was involved. Again, by using
immunoﬂuorescence microscopy, colocalization with ﬂotillin-1 was
assessed. As shown in Fig. 7, ﬂotillin-1 staining did not overlap withHRV8v (1% colocalization at both time points). Therefore, it is unlikely
that ﬂotillin-1 takes part in entry of HRV8v into RD cells via HS.
HRV8v induces ﬂuid-phase uptake and colocalizes with FITC-dextran
Next, we studied macropinocytosis as a candidate pathway for
viral entry. RD cells were challenged with HRV8v in the presence of
500 μg/ml of the ﬂuid-phasemarker FITC-dextran for 15 and 30 min at
34 °C. Cells were ﬁxed and examined by confocal ﬂuorescence
microscopy. Fig. 8A shows substantial (38%) colocalization of HRV8v
with FITC-dextran, which is considered ‘a relatively speciﬁc marker of
macropinocytosis’ (Falcone et al., 2006). These results suggest that
uptake via HS might occur by macropinocytosis. In the majority of cell
types macropinocytosis is not a constitutive process but is induced by
growth factors or viruses (Mercer and Helenius, 2009). As seen in
Fig. 8B, uptake of FITC-dextran was stimulated upon challenge of RD
cells with HRV8v. This stimulation was even stronger than that of
epidermal growth factor (EGF) used as a control. In accordance with
data on macropinocytosis of adenovirus (Meier et al., 2002), dextran
uptake decreased again at 30 min (not shown).
Pharmacologic inhibitors point to HRV8v entry via macropinocytosis
Finally, we examined the effect of various drugs on viral entry and
replication. These substances have been extensively employed to
speciﬁcally inhibit particular endocytic pathways. As in previous work
on HRV14 entry (Khan et al., 2010), we made use of cleavage of the
translation initiation factor eIF4GI as readout. This allows cutting
down the time of exposure to the drugs and thereby to minimize side
effects. Upon uncoating, the viral RNA is released into the cytoplasm
Fig. 4. HRV8v neither colocalizes with transferrin nor with GFP-clathrin. A) RD cells were incubated with HRV8v at 500 TCID50/cell along with 10 μg/ml Alexa Fluor 568-transferrin
for 5 and 15 min at 37 °C (continuous internalization). Unbound material was washed away, and cells were ﬁxed and stained for virus with type-speciﬁc mouse antiserum followed
by Alexa Fluor 488-labeled secondary antibody. B) RD cells were transfected with pEGFP-clathrin light chain and after 24 h cells were infected with HRV8v and processed as above.
Colocalization was assessed by confocal ﬂuorescence microscopy. One confocal slice is shown. Bar, 10 μm.
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the viral proteinase 2A that efﬁciently cleaves eIF4GI into fragments
that can be easily detected at 3 h pi. Thus, cleavage of eIF4GI is suitable
as a functional assay for productive entry as it only takes place on
arrival of the viral RNA in the cytosol and does not require viral
replication (Gradi et al., 1998). RD cells were pre-incubated with the
drugs indicated in Fig. 9A for 30 min, challenged with HRV8v, and
collected after 3 h. As previously described for poliovirus (Irurzun and
Carrasco, 2001) and HRV14 (Khan et al., 2010), cleavage of eIF4GI was
assessed via western blot analysis. Unprocessed eIF4GI and its
proteolysis products were quantiﬁed with ImageJ by using scanned
X-ray ﬁlms (Fig. 9B).
Although chlorpromazine (CPZ) is known to possess a number of
pleiotropic and cell type speciﬁc effects, it has been extensively used
to demonstrate CME of viruses (see for example Akula et al., 2003; Pu
and Zhang, 2008; Raghu et al., 2009; Van Hamme et al., 2008). In
agreement with the results above, eIF4GI cleavage upon HRV8vinfection was not inhibited by CPZ. Conversely, chlorpromazine
completely blocked eIF4GI cleavage in cells incubated with HRV2
that was used as a control (Khan et al., 2010 and data not shown).
Caveolin-mediated endocytosis is associated with lipid rafts.
Removal or sequestering of cholesterol profoundly inhibits entry of
CtxB and other ligands internalized via this route (Schnitzer et al.,
1994). Nystatin destroys the rafts by intercalating between choles-
terol molecules while methyl-ß-cyclodextrin (MßCD) extracts the
cholesterol from the membranes. Both result in impairment of
caveolin/lipid raft-dependent endocytosis. Whereas MßCD might
also affect CME and raft-dependent macropinocytosis, nystatin acts
more speciﬁcally on caveolar endocytosis (Smart and Anderson, 2002;
Stuart et al., 2002). MßCD decreased eIF4GI cleavage caused by HRV8v
infection by about 50% whereas nystatin was essentially without
effect. Together with the results above, this makes it unlikely that
caveolin is involved but suggests that lipid rafts may play some minor
role in HRV8v entry.
Fig. 5. Dominant negative inhibitors of the clathrin-dependent pathway do not affect HRV8v entry. RD cells were transfected with DN myc-tagged amphi-SH3 and AP180-C as
indicated and challenged with HRV8v at 300 TCID50/cell for 30 min at 34 °C (continuous internalization). Virus was detected with type-speciﬁc antiserum and TxR-labeled secondary
antibody, whereas expression of the DN inhibitors was assessed by using mouse anti-myc mAb followed by Alexa Fluor 488-labeled secondary antibody. Transferrin Alexa Fluor 568
was used as a control. Samples were processed and viewed as in Fig. 2. One confocal slice is shown. Bar, 10 μm.
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(EIPA) inhibit the Na+/H+ exchangers (Masereel et al., 2003).
Employed at mM and higher μM concentrations, respectively, they
havebeendemonstrated to inhibitmacropinocytosis of various viruses
and other ligands (Kalin et al., 2010; Karjalainen et al., 2008; Schneider
et al., 2007; West et al., 1989). The underlying mechanism has been
revealed only very recently (Koivusalo et al., 2010); they appear to
arrest cargo in a compartment close to the plasma membrane and
inaccessible from outside (Liberali et al., 2008). Cytochalasin D, on the
other hand, inhibits membrane rufﬂing and re-organization of the
actin cytoskeleton that are required for plasmamembrane engulfment
of liquid and ligands. Amiloride/EIPA completely inhibited cleavage of
eIF4GI by HRV8v while cytochalasin inhibited strongly, although not
completely. Dynasore, an inhibitor of the GTPase dynamin (Macia et
al., 2006) that is involved in membrane ﬁssion in a number of
endocytic pathways (Doherty and McMahon, 2009) also fully
inhibited eIF4GI cleavage on infection of the cells with HRV8v.
Although the above assay measures arrival and translation of the
viral RNA in the cytosol, we additionally addressed the effect of the
drugs on entry via de novo viral protein synthesis. Cells grown on
cover slips were pretreated with the drugs as in Fig. 9A but infected at
10 TCID50/cell, a multiplicity of infection which only allows for
detection of replicated virus; at this low MOI input virus remains
below the detection limit of immunoﬂuorescence microscopy. After
incubation for 10 h at 34 °C, intracellular virus was stained as in Fig. 1
and the number of infected cells was determined with a TissueFAXS
instrument. As seen in Fig. 9C, using production of viral protein as
readout, except for cytochalasin, the inhibitor proﬁle was quite similar
to that derived from eIF4GI cleavage. The latter drugmight only retard
RNA arrival in the cytosol (as seen from the strong inhibition of the
cleavage at 3 h pi) and replication could catch up during the longer
incubation period used in the assay based on viral synthesis. However,
this is so far purely hypothetic. Nevertheless, taken together, the data
in Fig. 9 indicate that the drugs speciﬁcally affect entry and that the
effects on viral replication are minor. Therefore, the results of these
experiments strongly support the data derived from immunoﬂuores-
cence microscopy colocalization and those of the dominant negative
mutants of key proteins of the various entry pathways.Dominant negative dynaminK44A inhibits viral entry and replication
In order to support the ﬁnding of dynamin-dependent entry of
HRV8v obtained with dynasore, we also carried out experiments by
using the mutant dynK44A. This dominant negative inhibitor of
dynamin 2 has been used in many studies to demonstrate dynamin
dependence of endocytosis for a given ligand. A plasmid directing
overexpression of wt dynamin (control) and mutant dynamin,
respectively, was transfected into RD cells. After allowing for synthesis
of the protein for 17 h, the cells were challenged with HRV8v at 20
TCID50/cell and viral replication was monitored at 17 h pi by indirect
immunoﬂuorescence microscopy. These conditions were chosen as to
obtain about 90% infected cells at the time of analysis. Fig. 10A
demonstrates the absence of viral antigen in those cells actively
producing dynK44A whereas virus productionwas not impaired in cells
overexpressing the wt protein. About 95% of the cells overexpressing
dynwt became infected, whereas in the dynK44A expressing cells only
about 14% showed viral replication (Fig. 10B). This is in accordance
with the inhibition of virus entry by dynasore (Fig. 9).
Electron microscopy of virus entry
The tubovesicular compartments involved in the diverse entry
pathways exhibit characteristic morphological features and clathrin-
coated pits, caveolae, and macropinocytic membrane invaginations
are distinguishable by electron microscopy (EM). Apart from these,
morphologically different tubular structures have been recently
implicated in other uptake mechanisms (Lundmark et al., 2008). We
thus studied entry of HRV8v by EM. RD cells were infected with
HRV8v for the times indicated in Fig. 11 and thin sections were
prepared. HRV8v was neither seen in coated pits/vesicles nor in
tubular structures but was rather found in shallow invaginations of
the plasma membrane. Many viruses aligned on the membrane and
were taken up in large vesicular structures. At 20 min, they
accumulated in irregularly shaped vesicles of about 0.5 μm diameter
similar to those reported for macropinocytic uptake of adenovirus
type 35 (Kalin et al., 2010). Importantly, as checked by EM of the
inoculum, the viral preparation used for infection was not aggregated
Fig. 6.HRV8v neither colocalizes with cholera toxin B nor with caveolin-1. A) RD cells were incubated with HRV8v at 500 TCID50/cell in the presence of 1 μg/ml Alexa Fluor 488-CtxB
for 5 and 15 min (continuous internalization) at 34 °C. Unbound material was washed away and cells were ﬁxed and stained for virus with type-speciﬁc mouse antiserum followed
by TxR-labeled secondary antibody. B) RD cells were transfected with pEGFP-caveolin-1 and caveolin-pEGFP, as indicated and after 24 h infected with HRV8v at 300 TCID50/cell for
30 min at 34 °C. Cells were ﬁxed and processed as above. Colocalization was assessed by confocal ﬂuorescence microscopy as in Fig. 3. Bar, 10 μm.
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they contact the cells. The morphologic characteristics of the virus-
ﬁlled vesicles are consistent with the previous results suggesting
dynamin-dependent macropinocytosis as a plausible entry route for
HRV8v bound to HS. It is of note that the ratio between infectious and
non-infectious HRV particles is generally very low (Abraham and
Colonno, 1984; Stott and Killington, 1972) and that we observed that
HRV8v readily lost infectivity upon puriﬁcation. Therefore, the
concentration of physical viral particles is most likely much higher
than the TCID50/ml applied.
Discussion
Absence of co-localization with established markers of clathrin-
and caveolin-dependent endocytosis demonstrated that HRV8v, when
entering via HS, exploits neither of these pathways. Regarding the
possible involvement of caveolin, in addition, we found much higherexpression of this protein in the ICAM-1 negative COS-7 cells than in
RD cells. However, HRV8v entered the two cell lines with equal
efﬁciency (data not shown). Thus, involvement of clathrin and
caveolin is highly unlikely.
The pharmacological inhibitor proﬁles corroborated the immuno-
ﬂuorescence data. Taking cleavage of eIF4GI at 3 h pi as readout for
successful entry, a possible inﬂuence of the drugs on later steps in
infection, such as modiﬁcation of RNA synthesis and/or virus release,
as previously suggested for HRV2 (Gazina et al., 2005), was excluded.
Of the compounds tested, amiloride and EIPA, inhibitors of Na+/H+
exchangers, and dynasore that blocks dynamin function, abolished
cleavage of eIF4GI in RD cells challenged with HRV8v. The role of
functional dynamin in HRV8v entry was also assessed by use of the
dominant-negative dynamin mutant K44A whose overexpression
strongly reduced viral replication. Cytochalasin D, an inhibitor of actin
polymerization, inhibited cleavage strongly but not completely. A
similar degree of inhibition of eIF4GI cleavage was seen with
Fig. 7. Flotillin does not colocalize with HRV8v. RD cells were infected with HRV8v at 500 TCID50/cell for 5 and 15 min at 37 °C (continuous internalization), unbound virus was
removed, and the cells were ﬁxed. Flotillin-1 was stained with rabbit anti-ﬂotillin-1 antibody followed by TxR-conjugated secondary antibody. Virus was detected with type-speciﬁc
antibody followed by Alexa Fluor 488-labeled secondary antibody. Cells were processed and viewed as in Fig. 3. One single confocal slice is shown. Bar, 10 μm.
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also retard transfer of HRV2 from early to late endocytic compart-
ments (Brabec et al., 2006), interpretation of this result is difﬁcult.
We also measured viral uptake in the presence of drugs by
automatically counting virus-replicating cells in a TissueFAXS instru-
ment followed by quantiﬁcation by the TissueQuest software. Except
from the discrepancy with cytochalasin D, which showed weaker
inhibition in these experiments when compared to the cleavage assay,
the drug-inhibition proﬁles of the two methods are quite similar and
again support the results of immunoﬂuorescence microscopy. It is
noteworthy that expression of the dominant negative mutants of
amphiphysin and AP180 somewhat increased uptake of HRV8v. This is
corroborated by a small increase in eIF4GI cleavage in the presence of
chlorpromazine and nystatin, respectively. This might indicate that
inhibition of CME and caveolin/lipid raft endocytosis results in an up-
regulation of the pathway exploited by HRV8v. Collectively, the data
strongly indicate a clathrin- and caveolin independent uptake of
HRV8v via HS and rather point to one of the pathways discussed
below.
Macropinocytosis and CLIC/GEEC (clathrin-independent carriers/
GPI-enriched early endosomal compartments), are only recently
becoming better deﬁned via attempts at establishing a correlation of
key proteins, such as ﬂotillin, CtBP1/BARS (C-terminal binding protein
1/brefeldin A-ADP ribosylated substrate), and GRAF1 (GTPase
regulator associated with focal adhesion kinase-1) with morpholog-
ical characteristics (Hansen and Nichols, 2009; Lundmark et al., 2008).
Experiments by Payne et al. (2007) on uptake of proteoglycan-binding
ligands pointed to the involvement of ﬂotillins. However, as ﬂotillins
require hetero-oligomerization for function (Babuke et al., 2009), lack
of co-localization of HRV8v with ﬂotillin-1 makes involvement of this
and any other ﬂotillin homologues highly unlikely. In macropinocy-
tosis, at least in some cell types, vesicles are being severed from the
plasma membrane by CtBP1/BARS (Bonazzi et al., 2005; Liberali et al.,
2008), one of several homologues involved in transcriptional
repression, Golgi to plasma membrane transport and endocytosis
(Gallop et al., 2005). Since dynamin is deﬁnitely required for HRV8v
entry, involvement of CtBP1/BARS is unlikely, as these two proteins
exert similar but presumably mutually exclusive functions.
Amiloride and its more active derivative EIPA are generally
accepted as relatively speciﬁc inhibitors of macropinocytosis. Like-wise, drugs interfering with actin polymerization also inhibit macro-
pinocytosis. Finally, stimulation of ﬂuid phase uptake, usually
determined via engulfment of ﬂuorescent dextran, is widely accepted
as an indicator for macropinocytosis. Cargo, such as dextran, thereby
accumulates in comparatively large vesicles. Based on all these
criteria, HRV8v enters via macropinocytosis. The weak (about 50%)
inhibition by MßCD does not contradict this view as a role of
cholesterol but not of caveolae in macropinocytosis has been
demonstrated in A431 cells (Grimmer et al., 2002). On the other
hand, in HRV8v endocytosis, dynamin apparently takes part in
scission of the vesicles from the plasma membrane.
HRV14, when entering via ICAM-1, exhibits a very similar behavior
with respect to co-localization with speciﬁc markers but its inhibitor
proﬁle is quantitatively different; inhibition by dynasore and
cytochalasin D is only partial whereas there is virtually no inhibition
by MßCD (Khan et al., 2010). However, it is possible that the ‘natural’
entry pathway is modiﬁed by the high expression level of ICAM-1 in
the RD-ICAM cells (Khan et al., 2010). Unfortunately, the double
speciﬁcity of HRV8v does not allow for assessing whether HRV14,
bound to ICAM-1, and HRV8v, bound to HS, travel along the same
pathway.
Most remarkably, HRV14 and HRV8v localized in morphologically
different invaginations. HRV14 accumulated in long tubules in RD-
ICAM cells (Khan et al., 2010) and in BHK cells overexpressing human
ICAM-1 (Grunert et al., 1997) appearing similar to the tubular
invaginations seen for adenovirus 3 entering HeLa cells by macro-
pinocytosis (Amstutz et al., 2008). On the other hand, numerous,
apparently aggregated HRV8v particles, were seen attached to the
cellular surface. These localized, at 20 min pi, in relatively large (about
500 nm diameter) vesicles. The virions did not stick to each other
prior to addition to the cells. Therefore, it is conceivable that HS shed
from the cells (Fitzgerald et al., 2000; Fux et al., 2009) leads to this
massive aggregation. We cannot exclude that this aggregation directs
HRV8v into an unusual pathway not followed at much lower
concentrations where the virions are presumably mono-disperse.
With respect to the strict requirement for dynamin, HRV8v differs
from enterovirus 1 (EV1) entering in a clathrin and caveolin
independent way via α2β1 into Saos-2 human osteosarcoma cells
transfected to express this integrin; in these cells, EV1 ﬁnally arrives
in caveosomes (Karjalainen et al., 2008). It also differs from
Fig. 8. HRV8v colocalizes with FITC-dextran and stimulates its uptake. A) RD cells were
infected with HRV8v at 300 TCID50/cell (continuous internalization) in the presence of
500 μg/ml lysine-ﬁxable FITC-dextran at 34 °C for 15 min, washed, and prepared for
immunoﬂuorescence microscopy as in Fig. 3. Bar, 10 μm. B) FITC-dextran uptake was
quantiﬁed by FACS analysis as the mean of cell-associated ﬂuorescence at 10 min
internalization. EGF was used as a control. The graph shows percent increase of the
signal with respect to the mean ﬂuorescence observed without stimulation (i.e. in the
absence of EGF and HRV8v). Mean of 3 separate experiments±SD.
Fig. 9. Inhibition proﬁle of pharmacological inhibitors. Cells were grown in 24 well
plates until 90% conﬂuent. The drugs were added at the concentrations indicated in
Materials and methods and incubated for 30 min. Then, virus was added at 300 TCID50/
cell and incubation continued for further 3 h. After removal of the supernatant, the cells
were harvested in sample buffer and proteins were separated on a SDS 6%
polyacrylamide gel. A) Cleavage of eIF4G1 was monitored via western blotting with a
rabbit antiserum followed by HRP-conjugated anti-rabbit antibodies and proteins were
detected by chemiluminescence recorded on X-ray ﬁlm. B) Cleavage was quantiﬁed
with ImageJ by using scanned ﬁlms from three independent experiments, including the
one shown in A). C) Infection was with 10 TCID50/cell and viral entry plus replication
was quantiﬁed at 10 h pi with a TissueFAXS instrument relating the cells infected in the
presence of the drugs to the number of cells infected in the absence of inhibitors. Data
are the mean of three independent experiments±SD. Inhibitors used are indicated; –,
control (no inhibitor); Chlor, chlorpromazine; Nyst, nystatin; MßCD, methyl-ß-
cyclodextrin; Amilo, amiloride; CytoD, cytochalasin; Dyna, dynasore; Mock, mock-
infected.
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binding to various αv integrins and CD46 (Amstutz et al., 2008), and
from coxsackievirus B3 entry into Caco-2 cells by macropinocytosis
exhibiting aspects of caveolar endocytosis (Coyne et al., 2007). Uptake
of the former viruses does not require functional dynamin. However,
at least in HeLa-K cells, adenovirus 3 and 35 appear to require
dynamin (Amstutz et al., 2008; Kalin et al., 2010). Hence, our data
provide additional evidence for the existence of a dynamin dependent
but clathrin- and caveolin-independent uptake mechanism in RD
cells. Very recently, Heikkila and colleagues similarly reported that
Coxsackie A9 virus, when bound to integrin αvß6, was taken up into
A549 cells by some form of macropinocytosis dependent on dynamin
in a clathrin and caveolin independent manner (Heikkila et al., 2010).
As demonstrated by inhibition with baﬁlomycin, HRV8v requires
acidic pH for uncoating and productive infection when entering via
HS. This is also supported by its co-localization with EEA1 at 37 °C at
30 min pi (data not shown). It thus differs from EV1, which travels
from macropinosomes to (non-acidic) caveosomes, although not via
caveolae (Karjalainen et al., 2008; Liberali et al., 2008). The viruses
mentioned above use receptors different from HS but show various
aspects of macropinocytosis. It is thus necessary to compare alsoHRV8v uptake with that of another HS-binding picornavirus, the
FMDV variant O1C3056R. This virus enters MCF-10A cells via caveolae
and is not inhibited by amiloride; it is not entirely clear whether it
follows the classical caveolar pathway (O'Donnell et al., 2008). As
FMDV also depends on low pH for infection, it must be directed into
acidic compartments. Indeed, at least glycosylphosphatidylinositol
(GPI)-anchoredmolecules entering via caveolae can reach endosomes
(Maxﬁeld and Mayor, 1997). Since most HS is linked to proteins
carrying GPI (Filmus et al., 2008), viral arrival in acidic compartments
is not unexpected. In any case, many distinct entry pathways converge
in early (sorting) endosomes and consequently, in mildly acidic
compartments (Jones, 2007). Vaccinia virus is yet another pathogen
Fig. 10. Dominant negative inhibitor dynK44A blocks HRV8v entry into RD cells. RD cells
were transfected with a plasmid encoding GFP-tagged wt dynamin 2 and dominant
negative mutant dynK44A, respectively and left for 17 h to allow for expression. Cells
were challenged with HRV8v at 20 TCID50/cell and ﬁxed at 17 h pi. Virus was revealed
with type speciﬁc antibody followed by Alexa586-labeled secondary antibody. A) Cells
were processed and viewed under the ﬂuorescence microscope. Bar, 10 μm. Arrows
point to HRV8v-infected cells, arrowheads to uninfected cells. B) About 400 cells
expressing GFP-dynwt and GFP-dynK44A were scored for viral replication, which is given
as percentage. Data are the mean±SEM of four experiments.
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which might be required for uptake since blebbistatin resulted in a
strong decrease in intracellular virus. Viral entry was prevented by
EIPA but not by dynasore. However, the unusual apoptotic mimicry
operating in this case adds a further dimension to this mechanism
(Mercer and Helenius, 2008). Taken together, formation and ﬁnal fate
of vesicles possessing properties of macropinosomes depend on the
cell type. The pathway exploited by HRV8v combines characteristics
of ‘classical’ macropinocytosis with unusual features. So far, several
virus types have been shown to exploit macropinocytosis-like uptake
mechanisms to breach the cell membrane for infection (reviewed in
Mercer and Helenius, 2009). Our work adds amajor group subgenus A
rhinovirus to this collection and demonstrates the existence of a
dynamin-dependent macropinocytosis-like pathway in RD cells. It
gradually becomes accepted that non-clathrin non-caveolin depen-
dent pathways follow various mechanisms and strikingly differ indifferent cell-types, a fact reﬂected in different drug-inhibition
proﬁles and involvement of key proteins (Sandvig et al., 2008). To
gain more insight into the contribution of receptor and virus to the
mode of entry, where possible, the use of the same cell type will be
mandatory in future studies of cellular uptake of different viruses.
Materials and methods
Cells and viruses
Rhabdomyosarcoma (RD) cells, wt and stably transfected with
human ICAM-1 (RD-ICAM), a kind gift of Darren Shafren (Univ. of
Newcastle, Australia), were cultured as previously described (Khan et
al., 2010; Newcombe et al., 2003). HeLa-H1 cells (for short called HeLa
cells) were grown in MEM supplemented with 10% heat inactivated
fetal calf serum (FCS), 100 U/ml penicillin, 100 μg/ml streptomycin,
and 2 mM L-glutamine. For infection, DMEM supplemented with
30 mM MgCl2, 2% FCS, and antibiotics (infection medium) was used.
CHO-K1 cells and CHOmutants (pgsA-745 and pgsD-677) deﬁcient in
proteoglycan biosynthesis and HRVs were originally obtained from
the ATCC; HRV8v, a variant of HRV8 replicating in RD cells was
obtained by 3 serial passages alternating betweenHeLa and RD cells as
previously described for HRV89 (Reischl et al., 2001). Brieﬂy, RD cells
were challenged with HRV8 at 100 TCID50/cell in 24 well plates. After
a 48 h incubation at 34 °C, the cells were broken and cleared
supernatants were transferred onto HeLa cells. After 24 h, the HeLa
cells were broken and the supernatants were transferred to RD cells.
This procedure was repeated twice. Serotypic identity of variant and
wt was conﬁrmed by neutralization with type-speciﬁc guinea pig
antiserum against HRV8 from ATCC. All experiments were conducted
with three-time plaque-puriﬁed virus.
Virus binding and infection assays
HRV8 was labeled using standard methods. Cells grown in 24 well
plates up to 90% conﬂuency were challenged with [35S]-labeled HRV8
at 12,000 cpm for 1 h at room temperature. Cells were washed with
ice cold PBS, trypsinized and collected in scintillation vials. Cell-
associated radioactivity wasmeasured by liquid scintillation counting.
For binding inhibition assays, RD cells were challenged with
radioactive virus as above in the presence or absence of 2 mg/ml
heparin for 1 h and processed for scintillation counting as above. For
infection of RD cells and its inhibition with heparin, cells were grown
in 96 well plates up to 70% conﬂuency and infected with HRV8v at 10
TCID50/cell in the presence or absence of 2 mg/ml heparin. After 24 h
incubation at 34 °C, cell death was assessed by staining the cells with
crystal violet.
Acid sensitivity of the virus
Virus at about 107 TCID50 was incubated with isotonic 100 mM
MES buffer of the pH values given in Fig. 1 for 30 min at 34 °C and
neutralized with 0.5 M Na3PO4. Infectivity was determined by an end
point dilution assay (Khan et al., 2007).
Antibodies and reagents
Mouse anti-HRV8, rabbit anti-HRV89, and rabbit anti-HRV14 were
produced following standard protocols. For co-localization experi-
ments, combinations of antibodies from different species were used.
Rabbit anti-caveolin and rabbit anti-ﬂotillin-1 antibodies were
purchased from Santa Cruz Biotechnology. Secondary antibodies
labeled with Texas red, Alexa Fluor 488, and Alexa Fluor 591,
respectively, were from Jackson ImmunoResearch Laboratories and
Molecular Probes, Invitrogen, respectively. Alexa Fluor 568 transfer-
rin, Alexa Fluor 488 cholera toxin-B, and lysine-ﬁxable FITC-dextran
Fig. 11. Transmission electron microscopy of thin sections of cells infected with HRV8v. RD cells grown on cover slips were infected with HRV8v at 170 TCID50/cell for the times
indicated at 34 °C. Cells were treated with glutaraldehyde and OsO4, embedded in resin, cut into 70 nm slices, and viewed at 36,000× magniﬁcation. Several ﬁelds are shown for
better appreciation. The lower right panel shows HRV8v (at 56,000×) suspended in serum-free infection medium as it was used for inoculation. It indicates lack of aggregation in the
absence of cells. Bar, 200 nm.
65A.G. Khan et al. / Virology 412 (2011) 55–67were from Molecular Probes, Invitrogen. The following drugs were
purchased from Sigma, stock solutions made in the indicated solvents
and used at the ﬁnal concentrations given in parentheses; chlor-
promazine in PBS (5 μg/ml); nystatin in DMSO (10 μg/ml); MßCD in
PBS (5 mM), amiloride (5 mM), cytochalasin D (10 μg/ml), dynasore
(80 μM), and EIPA (40 μM) all in DMSO.
Drug treatment
RD cellswere seeded in 24well plates, pre-incubated in the presence
or absence of the respective drug for 30 min and infectedwithHRV8v at
300 TCID50/cell. Samples were harvested in 50 μl sample buffer at 3 h pi
for assessment of eIF4GI cleavage via western blotting. Drugs were
present throughout the incubation. To evaluate entry plus replication,
cells grown on coverslips were preincubated with the drugs as above
but with slightly lower concentrations to avoid cytotoxicity due to the
longer incubation period; chlorpromazine, MßCD, and cytochalasin D
were used at 3 μg/ml, 3 mM and 5 μg/ml respectively. Amiloride was
replaced with EIPA, which was used at 40 μM. Cells were challenged
with virus at 10 TCID50/cell and further incubated. At 10 h pi, they were
washed, ﬁxed, and stained for de novo synthesized viral protein as
describedbelow. Thepercentage of infected cellswasdeterminedwith a
TissueFAXS, quantiﬁedwith TissueQuest software (TissueGnostics) and
related to those infected in the absence of drugs. Themask (i.e. the kind
of staining to be considered by the program as infection) was manually
adjusted by comparing infected cells and cells in which uncoating (and
infection) was prevented by baﬁlomycin. This also served as control for
‘background’ immunostainingof input virus. In eachexperiment, 10,000
cells were counted.
Western blot analysis
Proteins from whole cell lysates from each drug treatment were
separated on a SDS-6% polyacrylamide gel and electro-transferred
onto a PVDF membrane. The membrane was blocked with 5% milk
powder in PBS containing 0.1% Triton X100 (PBS/T), incubated with
rabbit anti-eIF4GI (1:8000) kindly donated by R. Rhoads, LouisianaState University, USA, followed by HRP-labeled anti-rabbit antibody
(1:20,000; Jackson Laboratories). Uncleaved and cleaved eIF4GI were
visualized on X-ray ﬁlm by using the ECL chemiluminescence
detection system (Thermoscientiﬁc). Proteolysis was quantiﬁed
from the scanned ﬁlms with ImageJ (http://rsbweb.nih.gov/ij/).
Confocal ﬂuorescence microscopy
Cells were grown on glass cover slips until 40–50% conﬂuent. After
washingwith serum-free medium, they were challenged with virus at
TCID50/cell as speciﬁed in the ﬁgure legends. Unbound virus was
removed by three washings with PBS++ (PBS with 1 mM MgCl2 and
1 mM CaCl2). Cells were ﬁxed with 4% paraformaldehyde, and
permeabilized in 0.2% Triton X100 for 5 min. After quenching with
50 mM NH4Cl for 10 min, unspeciﬁc binding sites were blocked with
1% goat serum for either 1 h at room temperature or overnight at 4 °C.
Cells were further incubated for 1 h at room temperature with
primary antibody (1:500), washed 3 times with PBS++, followed by
secondary antibody (1:400), all diluted in 1% goat serum. Nuclei were
stained with 0.1 μg/ml DAPI. For assessment of colocalization, cells
were infected in the presence of 10 μg/ml Alexa Fluor 568 transferrin,
1 μg/ml Alexa Fluor 488 CtxB, and 500 μg/ml lysine-ﬁxable ﬂuoresce-
in-dextran (70 kDa), respectively. Unbound material was removed
and cells were ﬁxed. Virus was detected by using type-speciﬁc
antibodies as above. Cover slips were mounted in Moviol and viewed
in a LSM510 Meta Carl Zeiss confocal microscope. Stacks were spaced
by 0.5 μm. Contrast of the pictures was adjusted with LSM Image
Browser (Carl Zeiss); lettering was done in Adobe Photoshop.
Colocalization was quantiﬁed by using BioImageXD software
(http://www.bioimagexd.net).
Transfection
The plasmids pEGFP-C3, encoding the clathrin light chain fused to
green ﬂuorescent protein (GFP-clathrin), myc-tagged pCMV-Amph-SH3,
and pMCV-AP180 were kind gifts from Luc Snyers, Med. Univ. Vienna.
They have been used and described previously (Snyers et al., 2003).
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wild type and the mutant K44A) were kindly provided by Ari Helenius,
Zurich, Switzerland. Cellswere seeded on cover slips in 24well plates and
grown to 30% conﬂuency. One μg plasmid DNA was mixed with 50 μl
Optimem (Gibco). Separately, 2 to 3 μl Lipofectamine 2000 (Invitrogen)
was mixed with 50 μl Optimem and incubated for 5 min at room
temperature; the2solutionsweremixedgently and incubationcontinued
for 20 min. Cells werewashed twice with antibiotic-free growthmedium
and laid down with 500 μl of the same medium. The mixture of plasmid
DNAandLipofectamine2000wasappliedonto the cellsdropbydropwith
gentle rotation to avoid cell toxicity. Cells were incubated for 3 hwith the
mixture; themediumwas then replacedwith fresh antibiotic-free growth
medium. Twenty-fourhours post transfection cellswere infectedwith the
respective virus and processed for immunoﬂuorescence microscopy. For
Amphi-SH3 and AP-180C anti-myc antibody was used to detect
expression. In case of the dynamin-2 constructs, after 17 h, cells were
infected at 20 TCID50/cell and stained for virus synthesis at 17 h pi.Uptake of FITC-dextran
RD cells were grown in 24 well plates up to 90% conﬂuence and
incubated with serum-free medium for 4 h at 37 °C. Lysine-ﬁxable
FITC-dextran at 0.5 mg/ml was added in the presence or absence of
HRV8v at 1000 TCID50/cell and 100 ng/ml EGF, respectively, and
incubated for the times indicated in the ﬁgure legends. Cells were
washed with ice cold PBS and detached with trypsin at 4 °C, collected
and resuspended in PBS containing 7% FCS. In each experiment, the
mean ﬂuorescence of 10,000 cells was determined in a BD FACS
Calibur.Electron microscopy
RD cells were seeded on Aclar cover-slips in 24 well plates and
grown to almost 100% conﬂuency. Cells were washed and infected
with HRV8v at 170 TCID50/cell. Note, however, that due to the well
known high ratio between physical particles and infectious units the
virus concentration might be more than 1000 times higher (Stott and
Killington, 1972). After incubation at 34 °C for the given times, cells
were washed twice with PBS and ﬁxed with 2% freshly prepared
glutaraldehyde for 1 h at room temperature. Cells were washed three
times with 0.1 M Sorensen buffer (pH 7.3) and incubated for 1 h in 2%
osmium tetroxide in the same buffer. After washing, cells were
dehydrated in ascending concentrations of ethanol (40%–60%–80%–
95% and 100%; kept over a molecular sieve), incubated with Epon/
100% EtOH (1:1) and twice with Epon only, for 30 min each,
embedded in resin-ﬁlled beam capsule lids, and incubated at 60 °C
to polymerize for 2 days. Sections of 70 nm were prepared, stained
with 2% uranyl acetate and lead citrate for 10 and 5 min respectively.
Puriﬁed virus, taken up in serum-free infectionmediumwas adsorbed
to glow-discharged carbon-coated copper grids for 1 min, washed and
stained with 2% Na-phosphotungstate (pH 7.4) for 1 min. Samples
were viewed under an FEI Morgagni 80 kV electron microscope
equipped with an 11 megapixel CCD camera.
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